Developer docs
API playgroundTry for free, no card

Search company profiles

Deerfield Catalyst

Full company profile

uuid000pn7e

Namestring
Deerfield Catalyst
Websiteurl
dfcatalyst.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Deerfield Catalyst is a private medtech incubator founded in 2021 and headquartered in New York, formed as a joint initiative between Coridea, a proven medtech incubator with a history of innovation and exits, and Deerfield, an investment management firm committed to advancing healthcare through investment, information, and philanthropy. The company's stated purpose is to develop transformational medical technology solutions intended to improve patient outcomes and streamline care delivery. Rather than operating a defined product portfolio, it functions as an incubation vehicle, originating, developing, and seeding medtech ventures through its parent ecosystem.

The entity operates with a small team of 1-10 employees led by a five-person C-suite: Howard Levin as CEO and CMO, Mark Gelfand as CTO, Zoar Engelman as CSO, Adam Rosenwach as CBO, and Maybelle Jordan as CSO/Strategy. Its technology footprint is described as a "MedTech innovation development platform focused on healthcare solutions" without further proprietary features disclosed in available sources. Publicly identified portfolio and partner entities include CobiCure (a pediatric healthcare portfolio company launched in 2022) and Clinical Accelerator (a strategic collaborator announced in May 2022).

Deerfield Catalyst does not generate revenue through conventional product sales. Its revenue model is structured around portfolio exits and licensing royalties stemming from the ventures it incubates. Go-to-market activity is conducted through press releases distributed via PR Newswire and industry publications rather than direct sales or marketing channels. No funding rounds, M&A activity, regulatory actions, or disclosed financial metrics are present in the available source data, consistent with an early-stage incubator reliant on its parent backers for capital.

Short descriptiontext

Deerfield Catalyst is a private New York–based medtech incubator founded in 2021 as a joint initiative of Coridea and Deerfield, developing transformational medical technology solutions and seeding healthcare ventures for eventual exit or licensing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
medtech incubator, medical device development, healthcare innovation funding, medtech venture incubation, clinical technology incubation
Industry1 code
PRIMARYFSANAAAM
Accelerators & Incubators (Investor-Operated)
Product category
Medtech Incubator Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Incubator Portfolio Returns
TypeLicensing Royalties
Description

As an incubator backed by Deerfield (investment management firm), revenue is generated through successful exits and portfolio company valuations rather than direct product sales.

dfcatalyst.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Deerfield Catalyst is a medtech incubator that develops transformational medical technology solutions to improve patient outcomes and streamline care delivery. It combines resources from Coridea (a proven medtech incubator with a history of innovation and exits) and Deerfield (an investment management firm committed to advancing healthcare) to identify, incubate, and bring to market innovative medical devices and healthcare technologies through portfolio companies such as CobiCure.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Deerfield Catalyst is a medtech incubator that develops transformational solutions to improve patient outcomes and streamline care. The company combines resources from Coridea (a proven medtech incubator with history of innovation and exits) and Deerfield (an investment management firm committed to advancing healthcare through investment, information and philanthropy). As an incubator, the company focuses on developing medtech innovations rather than operating a defined product portfolio.

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Coridea is a proven medtech incubator with a history of innovation and exits. Together with Deerfield, they form Deerfield Catalyst to combine resources of two established healthcare pioneers for accelerating medtech innovation.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Clinical Accelerator announced collaboration with Deerfield Catalyst, a medtech incubator committed to developing transformational solutions to improve patient outcomes and streamline care.

Strategic tierPortfolioTypeStrategic or Co-development Partner
Description

CobiCure is a portfolio company launched by Deerfield Catalyst to change the course of pediatric healthcare, representing a transformational solution developed through the incubator.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Chicago-based healthcare incubator and accelerator supporting healthcare startups with mentorship, capital connections, and programming; overlapping startup development mission in healthcare.

TypeDirect peer
Description

Leading global medtech accelerator and incubator that runs a startup competition and mentorship program; targets the same medtech founders and offers similar incubation-style support to portfolio companies.

3Fogarty Innovation
TypeDirect peer
Description

Non-profit medtech incubator and accelerator based in the Bay Area, focused on early-stage medical device companies; similar mission of moving transformational medtech from concept to commercialization.

TypeOthers
Description

Adjacent enabling organization in healthcare innovation ecosystem, but a university research entity rather than an operating medtech incubator.

TypeDirect peer
Description

Direct peer and founding partner: Coridea is itself a medtech incubator with a history of innovation and exits, combining with Deerfield to form Deerfield Catalyst. Same operating model, focus area, and target customer base.

TypeOthers
Description

Parent/financial backer and healthcare-focused investment management firm; comparable investor profile but operates as a fund manager rather than an operator-incubator, providing capital rather than direct incubation.

TypeBroad incumbent
Description

Bayer's global healthcare and life sciences incubator network offering lab, mentorship, and partnership opportunities to early-stage health ventures; comparable model within a much larger diversified pharma parent.

TypeBroad incumbent
Description

JLABS is the largest healthcare-focused incubator network operated by J&J; comparable in providing lab, mentorship, and capital access to early-stage medtech companies but as part of a much larger enterprise portfolio.

TypeDirect peer
Description

Early-stage investment group and syndicate focused on healthcare and medtech startups; comparable mission of funding and supporting medtech innovation from concept through commercialization.

TypeBroad incumbent
Description

Global startup accelerator with a dedicated Health and Wellness vertical that incubates, mentors, and invests in early-stage medtech and digital health ventures; broader portfolio but comparable model.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Deerfield Catalyst

Medtech Incubator Servicesdfcatalyst.com

Deerfield Catalyst is a private New York–based medtech incubator founded in 2021 as a joint initiative of Coridea and Deerfield, developing transformational medical technology solutions and seeding healthcare ventures for eventual exit or licensing.

What Deerfield Catalyst does

Deerfield Catalyst is a private medtech incubator founded in 2021 and headquartered in New York, formed as a joint initiative between Coridea, a proven medtech incubator with a history of innovation and exits, and Deerfield, an investment management firm committed to advancing healthcare through investment, information, and philanthropy. The company's stated purpose is to develop transformational medical technology solutions intended to improve patient outcomes and streamline care delivery. Rather than operating a defined product portfolio, it functions as an incubation vehicle, originating, developing, and seeding medtech ventures through its parent ecosystem.

The entity operates with a small team of 1-10 employees led by a five-person C-suite: Howard Levin as CEO and CMO, Mark Gelfand as CTO, Zoar Engelman as CSO, Adam Rosenwach as CBO, and Maybelle Jordan as CSO/Strategy. Its technology footprint is described as a "MedTech innovation development platform focused on healthcare solutions" without further proprietary features disclosed in available sources. Publicly identified portfolio and partner entities include CobiCure (a pediatric healthcare portfolio company launched in 2022) and Clinical Accelerator (a strategic collaborator announced in May 2022).

Deerfield Catalyst does not generate revenue through conventional product sales. Its revenue model is structured around portfolio exits and licensing royalties stemming from the ventures it incubates. Go-to-market activity is conducted through press releases distributed via PR Newswire and industry publications rather than direct sales or marketing channels. No funding rounds, M&A activity, regulatory actions, or disclosed financial metrics are present in the available source data, consistent with an early-stage incubator reliant on its parent backers for capital.

Deerfield Catalyst firmographics

Firmographics
Name
Deerfield Catalyst
Website
https://dfcatalyst.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Deerfield Catalyst is a private New York–based medtech incubator founded in 2021 as a joint initiative of Coridea and Deerfield, developing transformational medical technology solutions and seeding healthcare ventures for eventual exit or licensing.
Ownership category
akta.pro rank

Deerfield Catalyst industry classification

Industry
Product category
Medtech Incubator Services
akta.pro industry
PRIMARYFSANAAAM
Accelerators & Incubators (Investor-Operated)

Keywords

  • Medtech incubator
  • Medical device development
  • Healthcare innovation funding
  • Medtech venture incubation
  • Clinical technology incubation

Where Deerfield Catalyst is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Markets served

Deerfield Catalyst business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Incubator Portfolio Returns: As an incubator backed by Deerfield (investment management firm), revenue is generated through successful exits and portfolio company valuations rather than direct product sales.

Go-to-market motion1 record

Marketing channels1 record

Deerfield Catalyst product offering

Product offering

Core offering

Deerfield Catalyst is a medtech incubator that develops transformational medical technology solutions to improve patient outcomes and streamline care delivery. It combines resources from Coridea (a proven medtech incubator with a history of innovation and exits) and Deerfield (an investment management firm committed to advancing healthcare) to identify, incubate, and bring to market innovative medical devices and healthcare technologies through portfolio companies such as CobiCure.

Product overview

Deerfield Catalyst is a medtech incubator that develops transformational solutions to improve patient outcomes and streamline care. The company combines resources from Coridea (a proven medtech incubator with history of innovation and exits) and Deerfield (an investment management firm committed to advancing healthcare through investment, information and philanthropy). As an incubator, the company focuses on developing medtech innovations rather than operating a defined product portfolio.

Differentiator

Problem solved

Functional benefit

Companies that use Deerfield Catalyst

Customer profile

Segments1 record

Ideal customer profiles1 record

Deerfield Catalyst technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Deerfield Catalyst partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core, strategic and portfolio.

  • CorideacoreStrategic or Co-development PartnerCoridea is a proven medtech incubator with a history of innovation and exits. Together with Deerfield, they form Deerfield Catalyst to combine resources of two established healthcare pioneers for accelerating medtech innovation.
  • Clinical AcceleratorstrategicStrategic or Co-development PartnerClinical Accelerator announced collaboration with Deerfield Catalyst, a medtech incubator committed to developing transformational solutions to improve patient outcomes and streamline care.
  • CobiCureportfolioStrategic or Co-development PartnerCobiCure is a portfolio company launched by Deerfield Catalyst to change the course of pediatric healthcare, representing a transformational solution developed through the incubator.

Recent moves4 records

Expansion highlights3 records

Deerfield Catalyst competitors and assessment

Company assessment

Emerging players

  • Matter Health: Chicago-based healthcare incubator and accelerator supporting healthcare startups with mentorship, capital connections, and programming; overlapping startup development mission in healthcare.

Direct peers

  • MedTech Innovator: Leading global medtech accelerator and incubator that runs a startup competition and mentorship program; targets the same medtech founders and offers similar incubation-style support to portfolio companies.
  • Fogarty Innovation: Non-profit medtech incubator and accelerator based in the Bay Area, focused on early-stage medical device companies; similar mission of moving transformational medtech from concept to commercialization.
  • Coridea: Direct peer and founding partner: Coridea is itself a medtech incubator with a history of innovation and exits, combining with Deerfield to form Deerfield Catalyst. Same operating model, focus area, and target customer base.
  • HealthTech Capital: Early-stage investment group and syndicate focused on healthcare and medtech startups; comparable mission of funding and supporting medtech innovation from concept through commercialization.

Others

Broad incumbents

  • Bayer Co.Lab (CoLab): Bayer's global healthcare and life sciences incubator network offering lab, mentorship, and partnership opportunities to early-stage health ventures; comparable model within a much larger diversified pharma parent.
  • Johnson & Johnson Innovation – JLABS: JLABS is the largest healthcare-focused incubator network operated by J&J; comparable in providing lab, mentorship, and capital access to early-stage medtech companies but as part of a much larger enterprise portfolio.
  • Plug and Play Tech Center (Health Vertical): Global startup accelerator with a dedicated Health and Wellness vertical that incubates, mentors, and invests in early-stage medtech and digital health ventures; broader portfolio but comparable model.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key highlights5 records

Customer concentration

Deerfield Catalyst social profiles

Digital presence

Deerfield Catalyst financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Deerfield Catalyst leadership team

Management profile

Number of profiles

Profiles6 records

Deerfield Catalyst funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Deerfield Catalyst M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Deerfield Catalyst

What does Deerfield Catalyst do?

Deerfield Catalyst is a medtech incubator that develops transformational medical technology solutions to improve patient outcomes and streamline care delivery. It combines resources from Coridea (a proven medtech incubator with a history of innovation and exits) and Deerfield (an investment management firm committed to advancing healthcare) to identify, incubate, and bring to market innovative medical devices and healthcare technologies through portfolio companies such as CobiCure.

Is Deerfield Catalyst a public or private company?

Deerfield Catalyst is a private company. It is classified as corporate owned and is currently operating.

When was Deerfield Catalyst founded?

Deerfield Catalyst was founded in 2021. It employs 11 to 50 people.

Where is Deerfield Catalyst based?

Deerfield Catalyst is headquartered in New York, United States, in the North America region.

How does Deerfield Catalyst make money?

One revenue line is on record: incubator Portfolio Returns.

Who are Deerfield Catalyst's main competitors?

Matter Health is listed as an emerging player. Direct peers are MedTech Innovator, Fogarty Innovation, Coridea and HealthTech Capital. Others are California Health Sciences University Research & Innovation Cell and Deerfield Management Company. Broad incumbents are Bayer Co.Lab (CoLab), Johnson & Johnson Innovation – JLABS and Plug and Play Tech Center (Health Vertical).

Does Deerfield Catalyst have an API?

No public API is recorded for Deerfield Catalyst.

What industry is Deerfield Catalyst in?

Deerfield Catalyst's product category is Medtech Incubator Services. Its primary akta.pro industry code is FSANAAAM, Accelerators & Incubators (Investor-Operated).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales